According to #TechSci Research report, Global Coronavirus Vaccine Market is expected to grow at a robust rate by 2026 on account of the increasing research and development activities. Gain More Insight: https://bit.ly/3qmxDOw Get Sample Report: https://bit.ly/3EKdlWl Press Release: https://bit.ly/3vBIZko Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

1. GLOBAL CORONAVIRUS VACCINE
MARKET
FORECAST & OPPORTUNITIES
2016 – 2026
MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com

2. 2
Scope of Report
Product of Interest (POI): Coronavirus Vaccine
Review Period
2016 – 2019
Base Year
2020
Estimated Year
2021
Forecast Period
2022 – 2026
Year Range
A COVID-19 vaccine is a vaccine intended to provide acquired immunity
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
virus that causes coronavirus disease 2019 (COVID-19). The COVID-19
vaccines are widely celebrated for their role in reducing the spread, severity,
and death caused by COVID-19.
Market Segmentation
REGION
• Europe
• North America
• South America
• Middle East & Africa
• Asia Pacific
PRODUCT TYPE
• Monovalent Vaccine
• Multivariant Vaccine
VACCCINE TYPE
• Virus Vaccine
• Viral Vector Vaccine
• Nucleic Acid Vaccine
• Protein Based Vaccine
• Others
INFECTION TYPE
• SARS-CoV-2
• SARS-CoV
• MERS-CoV
ROUTE OF ADMINISTRATION
• Intramuscular
• Oral
• Intranasal
PATIENT TYPE
• Adult
• Pediatric
END USER
• Hospitals
• Clinics
• Research Institutes
• Others

3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview (Definition of product and major terminologies used in the report)
2. Research Methodology (Detailed description of the methodology used to conduct the research, Raw
data backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on Global Coronavirus Vaccine Market
4. Executive Summary (This chapter covers summary of the complete study.)
5.
Voice of Customer (Brand Awareness, Challenges Faced Post Purchase, Factors Influencing Purchase
Decision)
5.1. Brand Awareness
5.2. Vaccine Efficacy
5.3. Patient Satisfaction Analysis
5.4. Post-Vaccination Side Effects
6.
Global Coronavirus Vaccine Market Outlook, 2016-2026F (This chapter includes a brief overview of
the product of interest market such as total market’s growth rate, expected growth rate, key growth
levers, leading region, top grossing product Type, etc. It includes more of a qualitative information
about the market.)
6.1. Market Size & Forecast
6.1.1. By Value and By Volume
6.2. Market Share & Forecast
6.2.1. By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV)
6.2.2. By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based
Vaccine, Others)
6.2.3. By Product Type (Monovalent Vaccine v/s Multivariant Vaccine)
6.2.4. By Route of Administration (Intramuscular, Oral, Intranasal
6.2.5. By Patient Type (Adult v/s Pediatric)
6.2.6. By End User (Hospitals, Clinics, Research Institutes, Others)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Market Map

4. 4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Coronavirus Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value and By Volume
7.2. Market Share & Forecast
7.2.1. By Infection Type
7.2.2. By Vaccine Type
7.2.3. By Product Type
7.2.4. By Route of Administration
7.2.5. By Patient Type
7.2.6. By End User
7.2.7. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Coronavirus Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value and By Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Infection Type
7.3.1.2.2. By Vaccine Type
7.3.1.2.3. By Product Type
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By Patient Type
7.3.1.2.6. By End User
7.3.2. India Coronavirus Vaccine Market Outlook
7.3.2.1. Market Size & Forecast

5. 5
Table of Contents
S. No. Contents Page No.
7.3.2.1.1. By Value and By Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Infection Type
7.3.2.2.2. By Vaccine Type
7.3.2.2.3. By Product Type
7.3.2.2.4 By Route of Administration
7.3.2.2.5. By Patient Type
7.3.2.2.6. By End User
7.3.3. Australia Coronavirus Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value and By Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Infection Type
7.3.3.2.2. By Vaccine Type
7.3.3.2.3. By Product Type
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By Patient Type
7.3.3.2.6. By End User
7.3.4. Japan Coronavirus Vaccine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value and By Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Infection Type
7.3.4.2.2. By Vaccine Type

6. 6
Table of Contents
S. No. Contents Page No.
7.3.4.2.3. By Product Type
7.3.4.2.4 By Route of Administration
7.3.4.2.5. By Patient Type
7.3.4.2.6. By End User
7.3.5. South Korea Coronavirus Vaccine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value and By Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Infection Type
7.3.5.2.2. By Vaccine Type
7.3.5.2.3. By Product Type
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By Patient Type
7.3.5.2.6. By End User
7.3.6. Hong Kong Coronavirus Vaccine Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value and By Volume
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Infection Type
7.3.6.2.2. By Vaccine Type

7. 7
Table of Contents
S. No. Contents Page No.
7.3.6.2.3. By Product Type
7.3.6.2.4 By Route of Administration
7.3.6.2.5. By Patient Type
7.3.6.2.6. By End User
7.3.7. Singapore Coronavirus Vaccine Market Outlook
7.3.7.1. Market Size & Forecast
7.3.7.1.1. By Value and By Volume
7.3.7.2. Market Share & Forecast
7.3.7.2.1. By Infection Type
7.3.7.2.2. By Vaccine Type
7.3.7.2.3. By Product Type
7.3.7.2.4. By Route of Administration
7.3.7.2.5. By Patient Type
7.3.7.2.6. By End User
7.3.8. Thailand Coronavirus Vaccine Market Outlook
7.3.8.1. Market Size & Forecast
7.3.8.1.1. By Value and By Volume
7.3.8.2. Market Share & Forecast
7.3.8.2.1. By Infection Type
7.3.8.2.2. By Vaccine Type
7.3.8.2.3. By Product Type
7.3.8.2.4. By Route of Administration
7.3.8.2.5. By Patient Type
7.3.8.2.6. By End User

8. 8
Table of Contents
S. No. Contents Page No.
8. Europe Coronavirus Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value and By Volume
8.2. Market Share & Forecast
8.2.1. By Infection Type
8.2.2. By Vaccine Type
8.2.3. By Product Type
8.2.4. By Route of Administration
8.2.5. By Patient Type
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. France Coronavirus Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value and By Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Infection Type
8.3.1.2.2. By Vaccine Type
8.3.1.2.3. By Product Type
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By Patient Type
8.3.1.2.6. By End User

9. 9
Table of Contents
S. No. Contents Page No.
8.3.2. Germany Coronavirus Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value and By Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Infection Type
8.3.2.2.2. By Vaccine Type
8.3.2.2.3. By Product Type
8.3.2.2.4 By Route of Administration
8.3.2.2.5. By Patient Type
8.3.2.2.6. By End User
8.3.3. United Kingdom Coronavirus Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value and By Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Infection Type
8.3.3.2.2. By Vaccine Type
8.3.3.2.3. By Product Type
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By Patient Type
8.3.3.2.6. By End User

10. 10
Table of Contents
S. No. Contents Page No.
8.3.4. Italy Coronavirus Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value and By Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Infection Type
8.3.4.2.2. By Vaccine Type
8.3.4.2.3. By Product Type
8.3.4.2.4 By Route of Administration
8.3.4.2.5. By Patient Type
8.3.4.2.6. By End User
8.3.5. Spain Coronavirus Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value and By Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Infection Type
8.3.5.2.2. By Vaccine Type
8.3.5.2.3. By Product Type
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By Patient Type
8.3.5.2.6. By End User

11. 11
Table of Contents
S. No. Contents Page No.
9. North America Coronavirus Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value and By Volume
9.2. Market Share & Forecast
9.2.1. By Infection Type
9.2.2. By Vaccine Type
9.2.3. By Product Type
9.2.4. By Route of Administration
9.2.5. By Patient Type
9.2.6. By End User
9.2.7. By Country
9.3. North America: Country Analysis
9.3.1. United States Coronavirus Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value and By Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Infection Type
9.3.1.2.2. By Vaccine Type
9.3.1.2.3. By Product Type
9.3.1.2.4. By Route of Administration
9.3.1.2.5. By Patient Type
9.3.1.2.6. By End User

12. 12
Table of Contents
S. No. Contents Page No.
9.3.2. Mexico Coronavirus Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value and By Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Infection Type
9.3.2.2.2. By Vaccine Type
9.3.2.2.3. By Product Type
9.3.2.2.4 By Route of Administration
9.3.2.2.5. By Patient Type
9.3.2.2.6. By End User
9.3.3. Canada Coronavirus Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value and By Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Infection Type
9.3.3.2.2. By Vaccine Type
9.3.3.2.3. By Product Type
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By Patient Type
9.3.3.2.6. By End User

13. 13
Table of Contents
S. No. Contents Page No.
10. South America Coronavirus Vaccine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value and By Volume
10.2. Market Share & Forecast
10.2.1. By Infection Type
10.2.2. By Vaccine Type
10.2.3. By Product Type
10.2.4. By Route of Administration
10.2.5. By Patient Type
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Coronavirus Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value and By Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Infection Type
10.3.1.2.2. By Vaccine Type
10.3.1.2.3. By Product Type
10.3.1.2.4. By Route of Administration
10.3.1.2.5. By Patient Type
10.3.1.2.6. By End User

14. 14
Table of Contents
S. No. Contents Page No.
10.3.2. Argentina Coronavirus Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value and By Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Infection Type
10.3.2.2.2. By Vaccine Type
10.3.2.2.3. By Product Type
10.3.2.2.4 By Route of Administration
10.3.2.2.5. By Patient Type
10.3.2.2.6. By End User
10.3.3. Colombia Coronavirus Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value and By Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Infection Type
10.3.3.2.2. By Vaccine Type
10.3.3.2.3. By Product Type
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By Patient Type
10.3.3.2.6. By End User

15. 15
Table of Contents
S. No. Contents Page No.
11. Middle East and Africa Coronavirus Vaccine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value and By Volume
11.2. Market Share & Forecast
11.2.1. By Infection Type
11.2.2. By Vaccine Type
11.2.3. By Product Type
11.2.4. By Route of Administration
11.2.5. By Patient Type
11.2.6. By End User
11.2.7. By Country
11.3. Middle East and Africa: Country Analysis
11.3.1. South Africa Coronavirus Vaccine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value and By Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Infection Type
11.3.1.2.2. By Vaccine Type
11.3.1.2.3. By Product Type
11.3.1.2.4. By Route of Administration
11.3.1.2.5. By Patient Type
11.3.1.2.6. By End User

16. 16
Table of Contents
S. No. Contents Page No.
11.3.2. Saudi Arabia Coronavirus Vaccine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value and By Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Infection Type
11.3.2.2.2. By Vaccine Type
11.3.2.2.3. By Product Type
11.3.2.2.4 By Route of Administration
11.3.2.2.5. By Patient Type
11.3.2.2.6. By End User
11.3.3. UAE Coronavirus Vaccine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value and By Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Infection Type
11.3.3.2.2. By Vaccine Type
11.3.3.2.3. By Product Type
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By Patient Type
11.3.3.2.6. By End User

17. 17
Table of Contents
S. No. Contents Page No.
11.3.4. Kuwait Coronavirus Vaccine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value and By Volume
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Infection Type
11.3.4.2.2. By Vaccine Type
11.3.4.2.3. By Product Type
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By Patient Type
11.3.4.2.6. By End User
12. Market Dynamics (This chapter assesses the major demand drivers and restraints.)
12.1. Drivers
12.2. Challenges
13.
Market Trends & Developments (This section captures recent trends pertaining to manufacturing or
consumption, market movements in terms of points of production and consumption, advancements and
development)
14. Competitive Landscape
14.1. Competition Outlook
14.2. Global Players Profiled (Leading Companies)
14.2.1. Company Details
14.2.2. Products & Services
14.2.3. Financials (As Reported)
14.2.4. Key Market Focus & Geographical Presence

18. 18
Table of Contents
S. No. Contents Page No.
14.2.5. Recent Developments
14.2.6. Key Management Personnel
15.
Strategic Recommendations (Based on the findings of the report strategic recommendations on how
to enter and expand market share)
16. About Us & Disclaimer

19. RESEARCH
METHODOLOGY

20. 20
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global coronavirus
vaccine market, overall
market size and segmental
market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global coronavirus
vaccine market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

21. 21
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global coronavirus vaccine market.
segments of this market, while considering the major influencing factors such as increase use of coronavirus vaccine. The study
enable our clients to take better decisions while planning their strategy to achieve sustainability in the global coronavirus vaccine
Methodology Followed for Calculation of Market Size:
• Market Size by Value & Volume : Market size, in terms of value, for the year 2020 was calculated based on information
collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as
channel partners, market influencers & end users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 coronavirus vaccine manufacturers, 100 – 120 end users, and 15 – 20 industry
global coronavirus vaccine market to obtain the overall market size from 2016 to 2020, which was validated by the Delphi
consideration, the market size was averaged out, to arrive at the market size data during 2016-2020.

22. 22
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by infection type, by vaccine type, by product type, by route of administration,
by patient type, by end user, by company and by each region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares
generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various type were further triangulated from
other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market shares by infection type, by vaccine type, by product type, by route of administration, by patient type, by end user, by company and by each region were calculated
based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from
various types of coronavirus vaccine. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating
the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global coronavirus vaccine market, TechSci
Research used various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

23. 23
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
 Moderna, Inc.
 Pfizer Inc.
 .Johnson & Johnson SA
 Sinopharm Group Company Ltd.
 AstraZeneca PLC
 Serum Institute of India Pvt Ltd.
 Bharat Biotech International Ltd.
 Sinovac Biotech Ltd.
 Sanofi SA
 GlaxoSmithKline PLC
 Novavax, Inc.
 Airway Therapeutics, Inc.
 Cadila Healthcare Ltd.
 CanSino Biologics Inc.
 Mitsubishi Chemical Holdings Corporation
 Eubiologics Co. Ltd.
 United Biomedical Inc.
 Merck & Co., Inc.
 CureVac N.V.
 Inovio Pharmaceuticals, Inc.
 World Bank
 International Monetary Fund (IMF)
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

24. 24
Industry Brief
Growing cases of COVID-19 disease across the globe to drive the growth of global coronavirus vaccine market by 2026.
According to TechSci Research report, “Global Coronavirus Vaccine Market By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine
Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s
Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals,
Clinics, Research Institutes, Others), By Region, Forecast & Opportunities, 2026”, the global coronavirus vaccine market is expected to rise in 2021 and
2022 in value terms to reach USD91325.46 million in 2021. The global coronavirus vaccine market is expected to grow at a robust rate during the
forecast period on account of the increasing research and development activities related to manufacture of coronavirus vaccine by the major companies
and research laboratories around the globe. Additionally, increasing funding & grants by various governments around the world for development of
vaccine to contain coronavirus, is expected to foster the market over the next few years. Furthermore, increasing healthcare spending and rising need
to protect the population from the outbreak are positively impacting the growth of market.
The major challenge that will hamper the growth of coronavirus vaccine will be the post vaccination’s side-effects. After the administration of COVAXIN
developed by Bharat Biotech International Ltd and COVISHIELD by Serum Institute of India, swelling at the injection site, fever, body ache, nausea,
rashes, arm stiffness etc. are the common side effects post vaccination. The efficacy rate of the coronavirus vaccine will be the deciding factor for
choosing the vaccine, the efficacy rate of SPUTNIK developed by Gamaleya Research Institute is reported to be 91.6%, the efficacy rate of
COVISHIELD is 70.4% and that of COVAXIN is 78-81%.
Today, several COVID-19 vaccines have been approved to administer into public. In India, COVAXIN phase II/III clinical trials for pediatric children
falling in the age group of 2-18 has begun. Medicago along with GSK and Dynavax is developing plant based adjuvant vaccine (VIR-7831), which is
under phase III trial.
The global coronavirus vaccine market is segmented based on infection type, vaccine type, product type, route of administration, patient type, end user,
company, and region. Based on vaccine type, the market can be categorized into virus vaccine, viral vector vaccine, nucleic acid vaccine, protein based
vaccine and others. The virus vaccine is expected to hold the largest market share during forecast period since this is the most traditional method used
for the development of vaccines. While the protein based coronavirus vaccine is expected to register the highest growth since the most of the vaccines
that are under development and have entered the clinical trials are protein based ones. Based on patient type, the market can be bifurcated into
pediatric and adult. The adult segment is expected to dominate the market since mostly the adults especially the geriatric population, is getting affected
by the COVID-19 disease. However, in the forecast period pediatric patient type will be leading the market.
Some of the major competitors in the market are Moderna, Inc., Johnson & Johnson SA, Pfizer Inc., Sinopharm Group Company Ltd., AstraZeneca
PLC, Serum Institute of India Pvt Ltd., Bharat Biotech International Ltd., Sinovac Biotech Ltd., Sanofi SA, GlaxoSmithKline PLC, Novavax, Inc., Airway
Therapeutics, Inc., Cadila Healthcare Ltd., CanSino Biologics Inc., Mitsubishi Chemical Holdings Corporation, Eubiologics Co. Ltd., United Biomedical
Inc., Merck & Co., Inc., CureVac N.V., Inovio Pharmaceuticals, Inc. The companies are focusing on extensive research and development activities to
stay competitive in the market.
The companies operating in the market are using organic strategies such as product launches, mergers, and collaborations to boost their share. Bharat
Biotech has collaborated with the University of Wisconsin Madison and US-based company FluGen to develop a vaccine, Coro-Flu, against COVID-19.
“North America is expected to dominate the coronavirus vaccine market during the forecast period owing to the increasing R&D investments for the
development of a potential vaccine against the coronavirus in the region. Additionally, supportive government policies & schemes are further expected
to propel the market. Furthermore, the presence of major players such as Moderna, Inc., Pfizer Inc., Novavax, Inc., among others, who are aggressively
developing the vaccine, is expected to create lucrative opportunities for the market growth through 2026.” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm.

25. 25
Sample Data - Snapshot
Global Coronavirus Vaccine Market Size, By Value (USD Million) 7 By Volume (Units), 2016–2026F
5.00
6.00
7.00
8.00
9.00
10.00
11.00
12.00
13.00
14.00
15.00
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 110.00
2016 2020 2021E 2026F
By Value (USD Million)
By Volume (Units)
CAGR BY VALUE: XX%
CAGR BY VOLUME: XX%
CAGR BY VALUE: XX%
CAGR BY VOLUME: XX%
Asia-Pacific Coronavirus Vaccine Market Share, By Infection Type, By Value, 2016–2026F
40% 40% 40% 40% 40% 40% 40% 40% 40% 40% 40%
30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30%
30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30%
2016 2017 2018 2019 2020 2021E 2022F 2023F 2024F 2025F 2026F
MERS-CoV
SARS-CoV
SARS-CoV-
2
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
2016
2017
2018
2019
2020
2021E
2022F
2023F
2024F
2025F
2026F
Virus Vaccine Viral Vector Vaccine Nucleic Acid Vaccine Protein Based Vaccine Others
India Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2016–2026F

26. 26
Report Ordering
To View Sample OR Purchase Report
License Type Price
Single User License $4900
Multi-User License $5900
Custom Research License $8900
Report Name: GLOBAL CORONAVIRUS VACCINE MARKET
FORECAST & OPPORTUNITIES
2016 – 2026

27. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality
reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a
unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the
result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Mammography Devices Market By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis), By
Technology (Digital v/s Analog) By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition, Forecast & Opportunities,
2026.
• Global 3D Mobile C-Arm Market By Application (Orthopedics, Trauma, Cardiovascular, Urology, Gastroenterology, Neurology, Others) By End
Users (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics) By Region, Competition Forecast & Opportunities, 2026.
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com